This company has been marked as potentially delisted and may not be actively trading. ERYTECH Pharma (ERYP) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisCompetitorsTrendsBuy This Stock ERYTECH Pharma Short Interest DataERYTECH Pharma (ERYP) has a short interest of 17,800 shares. This marks a -53.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 93,510 shares to cover all short positions.Current Short Interest17,800 sharesPrevious Short Interest37,900 sharesChange Vs. Previous Month-53.03%Dollar Volume Sold Short$14,606.68Short Interest Ratio0.1 Days to CoverLast Record DateJune 15, 2023Outstanding Shares34,120,000 sharesPercentage of Shares Shorted0.05%Today's Trading Volume0 sharesAverage Trading Volume93,510 sharesToday's Volume Vs. Average0% Short Selling ERYTECH Pharma? Sign up to receive the latest short interest report for ERYTECH Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartERYP Short Interest Over TimeERYP Days to Cover Over TimeERYP Percentage of Float Shorted Over Time ERYTECH Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202317,800 shares $14,606.68 -53.0%N/A0.1 $0.82 5/31/202337,900 shares $35,622.21 -60.1%N/A0.3 $0.94 5/15/202395,000 shares $107,350.00 +138.7%N/A0.7 $1.13 4/30/202339,800 shares $34,307.60 +15.0%N/A0.3 $0.86 4/15/202334,600 shares $33,382.08 +2.1%N/A1.2 $0.96 3/31/202333,900 shares $33,222.00 -11.0%N/A1 $0.98 3/15/202338,100 shares $27,569.16 -0.8%N/A0.8 $0.72 2/28/202338,400 shares $32,670.72 -5.4%N/A0.8 $0.85 2/15/202340,600 shares $35,768.60 +12.8%N/A0.8 $0.88 1/31/202336,000 shares $32,403.60 -47.7%N/A0.7 $0.90 Get the Latest News and Ratings for ERYP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ERYTECH Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/202368,800 shares $34,056.00 +45.2%N/A1.8 $0.50 12/30/202247,400 shares $15,646.74 +9.7%N/A1.5 $0.33 12/15/202243,200 shares $21,600.04 -5.7%N/A1.4 $0.50 11/30/202245,800 shares $27,484.58 No ChangeN/A3 $0.60 11/15/202245,800 shares $29,770.00 -18.8%N/A3 $0.65 10/31/202256,400 shares $35,537.64 +46.1%N/A4 $0.63 10/15/202238,600 shares $27,108.78 -26.3%N/A3.1 $0.70 9/30/202252,400 shares $28,814.76 -12.2%N/A4.2 $0.55 9/15/202259,700 shares $47,760.00 -16.9%N/A4.9 $0.80 8/31/202271,800 shares $66,450.90 +17.5%N/A5.7 $0.93 8/15/202261,100 shares $78,208.00 +5.9%N/A4.7 $1.28 7/31/202257,700 shares $61,162.00 -6.8%N/A2.4 $1.06 7/15/202261,900 shares $64,376.00 -6.6%N/A0.1 $1.04 6/30/202266,300 shares $74,256.00 -9.8%N/A0.1 $1.12 6/15/202273,500 shares $77,175.00 -9.5%N/A0.1 $1.05 5/31/202281,200 shares $94,192.00 -15.9%N/A0.1 $1.16 5/15/202296,500 shares $105,185.00 -84.4%N/A0.1 $1.09 4/30/2022618,700 shares $829,058.00 +105.8%N/A0.7 $1.34 4/15/2022300,600 shares $357,714.00 +118.9%N/A0.4 $1.19 3/31/2022137,300 shares $240,275.00 -3.1%N/A1.3 $1.75 3/15/2022141,700 shares $253,728.02 -17.2%N/A3.7 $1.79 2/28/2022171,200 shares $303,024.00 -3.4%N/A4.4 $1.77 2/15/2022177,300 shares $333,324.00 +0.5%N/A1.5 $1.88 1/31/2022176,500 shares $338,880.00 +1.9%N/A1.4 $1.92 1/15/2022173,300 shares $400,323.00 -5.6%N/A1 $2.31 12/31/2021183,500 shares $431,225.00 -11.1%N/A1.1 $2.35 12/15/2021206,400 shares $474,720.00 +1,395.7%N/A1.2 $2.30 11/30/202113,800 shares $37,536.00 +62.4%0.1%0.1 $2.72 11/15/20218,500 shares $21,250.00 -57.1%0.0%0.1 $2.50 10/29/202119,800 shares $57,420.00 -66.3%0.1%0.2 $2.90Gold Hits New Highs as Global Markets Spiral (Ad)When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.Go Here to Learn What's Happening and How to Prepare >> 10/15/202158,800 shares $356,328.00 +279.4%0.2%0.1 $6.06 9/30/202115,500 shares $89,435.00 -30.5%0.1%0 $5.77 9/15/202122,300 shares $128,448.00 -35.4%0.1%0 $5.76 8/31/202134,500 shares $215,970.00 -70.5%0.1%0 $6.26 8/13/2021116,900 shares $688,541.00 +454.0%0.5%0.1 $5.89 7/30/202121,100 shares $134,407.00 +101.0%0.1%0 $6.37 7/15/202110,500 shares $46,200.00 +54.4%0.0%0.8 $4.40 6/30/20216,800 shares $32,844.00 +41.7%0.0%0.7 $4.83 6/15/20214,800 shares $25,632.00 +92.0%0.0%0.6 $5.34 5/28/20212,500 shares $14,681.50 +19.1%0.0%0.3 $5.87 5/14/20212,100 shares $13,671.00 +2,000.0%N/A0.3 $6.51 4/30/2021100 shares $700.00 -94.4%N/A0 $7.00 4/15/20211,800 shares $12,600.00 -60.0%N/A0.1 $7.00 3/31/20214,500 shares $31,815.00 -4.3%N/A0.2 $7.07 3/15/20214,700 shares $36,190.00 +6.8%N/A0.2 $7.70 2/26/20214,400 shares $38,148.00 -90.4%N/A0.2 $8.67 2/12/202145,900 shares $426,411.00 +856.3%N/A1.8 $9.29 1/29/20214,800 shares $49,488.00 -44.8%N/A0.2 $10.31 1/15/20218,700 shares $95,613.00 +690.9%N/A1.7 $10.99 12/31/20201,100 shares $10,769.00 +57.1%N/A0.2 $9.79 12/15/2020700 shares $6,251.00 -95.0%N/A0.2 $8.93 11/30/202014,100 shares $134,309.55 +642.1%N/A3.4 $9.53 11/15/20201,900 shares $14,915.00 -51.3%N/A0.6 $7.85 10/30/20203,900 shares $20,427.42 +225.0%N/A1.1 $5.24 10/15/20201,200 shares $7,256.16 -33.3%N/A0.3 $6.05 9/30/20201,800 shares $10,800.18 +260.0%N/A0.4 $6.00 9/15/2020500 shares $3,455.00 +25.0%N/A0.1 $6.91 8/31/2020400 shares $2,632.00 -50.0%N/A0.1 $6.58 8/14/2020800 shares $5,600.00 +166.7%N/A0.2 $7.00 7/31/2020300 shares $2,106.00 No ChangeN/A0.1 $7.02 7/15/2020300 shares $2,298.00 No ChangeN/A0.1 $7.66 6/30/2020300 shares $2,532.00 -70.0%N/A0.1 $8.44 6/15/20201,000 shares $9,250.00 -33.3%0.0%0.2 $9.25 5/29/20201,500 shares $12,946.95 +36.4%0.0%0.4 $8.63 5/15/20201,100 shares $8,514.00 -31.3%0.0%0.3 $7.74 ERYP Short Interest - Frequently Asked Questions What is ERYTECH Pharma's current short interest? Short interest is the volume of ERYTECH Pharma shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 17,800 shares of ERYP short. Learn More on ERYTECH Pharma's current short interest. Is ERYTECH Pharma's short interest increasing or decreasing? ERYTECH Pharma saw a drop in short interest in June. As of June 15th, there was short interest totaling 17,800 shares, a drop of 53.0% from the previous total of 37,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ERYTECH Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to ERYTECH Pharma: Sana Biotechnology, Inc. (32.45%), Tectonic Therapeutic (14.30%), Tourmaline Bio, Inc. (19.08%), Ginkgo Bioworks Holdings, Inc. (36.07%), Autolus Therapeutics plc (5.79%), Allogene Therapeutics, Inc. (20.67%), Solid Biosciences Inc. (12.52%), Atyr PHARMA INC (11.66%), Aura Biosciences, Inc. (4.36%), DBV Technologies S.A. (0.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.80 billion), Canadian Natural Resources Limited ($3.69 billion), Charter Communications, Inc. ($2.95 billion), Occidental Petroleum Co. ($2.78 billion), Moderna, Inc. ($2.38 billion), Palantir Technologies Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.19 billion), Coinbase Global, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($2.02 billion), and Verisk Analytics, Inc. ($1.96 billion). View all of the most shorted stocks. What does it mean to sell short ERYTECH Pharma stock? Short selling ERYP is an investing strategy that aims to generate trading profit from ERYTECH Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ERYTECH Pharma? A short squeeze for ERYTECH Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ERYP, which in turn drives the price of the stock up even further. How often is ERYTECH Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ERYP, twice per month. The most recent reporting period available is June, 15 2023. More Short Interest Resources from MarketBeat Related Companies SANA Short Interest Data TECX Short Interest Data TRML Short Interest Data DNA Short Interest Data AUTL Short Interest Data ALLO Short Interest Data SLDB Short Interest Data ATYR Short Interest Data AURA Short Interest Data DBVT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ERYP) was last updated on 5/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ERYTECH Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share ERYTECH Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ERYP Stock Free ERYP Stock Alerts